Zhuhai Rundu Pharmaceutical Co., Ltd.

Equities

002923

CNE1000033G8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
10.86 CNY +1.78% Intraday chart for Zhuhai Rundu Pharmaceutical Co., Ltd. +10.14% -11.99%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Rundu Pharmaceutical's Rabeprazole Sodium Tablets Chosen for China's Centralized Procurement MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhuhai Rundu Pharma Gets Supplementary Application Approval For Hypertension Drug MT
Rundu Pharmaceutical Gets Nod to Market Raw Drug Material MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2022, Payable on 31 May 2023 CI
Tianyu Pharmaceutical Unit Gets Approval to Market Hypertension Drug in China MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Management Appointments CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Rundu Pharmaceutical Unit Wins Drug Production License MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Proposes Cash Dividend for 2021 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Dividend for 2020, Payable on 28 May 2021 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Announces Final Dividend Profit Distribution Proposal for 2020 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Announces to Implement Final Cash Distribution Plan for 2019, Payable on 09 June 2020 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Cash Dividend CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Proposes Final Cash Dividend on A Share for 2019 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Election of Directors CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Announces 2018 Final Distribution Plan of (A Shares), Payable on 12 June 2019 CI
Chart Zhuhai Rundu Pharmaceutical Co., Ltd.
More charts
Zhuhai Rundu Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of chemical medicine preparations, chemical medicine raw materials and pharmaceutical intermediates. The Company’s products cover the fields of cardio-cerebral blood vessels, digestion and anesthesia, among others.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002923 Stock
  4. News Zhuhai Rundu Pharmaceutical Co., Ltd.
  5. Rundu Pharmaceutical Gets Nod to Market Raw Drug Material